ADAM10 and Alzheimer disease: Fortunately, RAGE is subject to ectodomain shedding by ADAM10, and the derived sRAGE can inhibit the Aβ-RAGE interaction, block Aβ influx across the BBB and alleviate RAGE-mediated cellular perturbation in AD (Zhang et al., 2009).